Aurora Cannabis (ACB) Competitors $5.27 +0.06 (+1.15%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$5.26 -0.01 (-0.28%) As of 04:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. CGC, CRON, OGI, SNDL, TLRY, VFF, XERS, PAHC, COLL, and NTLAShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Xeris Biopharma (XERS), Phibro Animal Health (PAHC), Collegium Pharmaceutical (COLL), and Intellia Therapeutics (NTLA). Aurora Cannabis vs. Its Competitors Canopy Growth Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Xeris Biopharma Phibro Animal Health Collegium Pharmaceutical Intellia Therapeutics Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk. Does the media prefer CGC or ACB? In the previous week, Aurora Cannabis had 5 more articles in the media than Canopy Growth. MarketBeat recorded 20 mentions for Aurora Cannabis and 15 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.05 beat Aurora Cannabis' score of -0.23 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 8 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 2 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk & volatility, CGC or ACB? Canopy Growth has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Which has higher valuation and earnings, CGC or ACB? Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanopy Growth$225.65M1.41-$429.86M-$3.03-0.51Aurora Cannabis$246.72M1.21$1.63M-$0.19-27.74 Do institutionals & insiders have more ownership in CGC or ACB? 3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer CGC or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Is CGC or ACB more profitable? Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Canopy Growth-155.76% -89.93% -44.24% Aurora Cannabis -5.66%-1.49%-1.06% SummaryAurora Cannabis beats Canopy Growth on 12 of the 16 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$294.12M$10.49B$5.49B$9.69BDividend YieldN/A2.01%4.64%4.14%P/E Ratio-27.7419.8030.4025.31Price / Sales1.2124.76444.45101.55Price / Cash8.5223.7337.7258.50Price / Book0.703.038.306.01Net Income$1.63M$211.77M$3.26B$265.10M7 Day Performance24.29%5.71%1.53%1.39%1 Month Performance17.37%6.33%3.73%2.43%1 Year Performance-21.23%-8.67%41.02%24.74% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.4496 of 5 stars$5.27+1.2%N/A-18.2%$294.12M$246.72M-27.741,130Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeCGCCanopy Growth0.6199 of 5 stars$1.58+26.4%N/A-75.6%$324.14M$225.65M-0.523,150Trending NewsEarnings ReportOptions VolumeGap UpHigh Trading VolumeCRONCronos Group1.4094 of 5 stars$2.67+16.1%N/A+18.5%$1.02B$117.61M53.40450Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeOGIOrganigram Global1.1998 of 5 stars$1.64+13.5%N/A+10.4%$219.81M$117.47M16.40860News CoverageGap UpHigh Trading VolumeSNDLSNDL2.8286 of 5 stars$2.01+19.3%$4.00+99.5%+0.5%$526.87M$944.25M-7.432,516News CoverageOptions VolumeHigh Trading VolumeTLRYTilray Brands2.9032 of 5 stars$0.92+41.7%$1.92+108.6%-46.8%$1.01B$821.31M-0.402,842Trending NewsOptions VolumeGap UpHigh Trading VolumeVFFVillage Farms International2.6203 of 5 stars$2.31+34.3%N/A+156.3%$259.51M$336.18M-6.421,400Earnings ReportHigh Trading VolumeXERSXeris Biopharma2.8797 of 5 stars$7.20+5.3%$6.25-13.2%+224.4%$1.16B$203.07M-34.28290News CoverageEarnings ReportAnalyst ForecastPAHCPhibro Animal Health4.1851 of 5 stars$28.54+1.6%$24.40-14.5%+71.7%$1.16B$1.02B36.591,940COLLCollegium Pharmaceutical3.0875 of 5 stars$36.14+3.5%$42.33+17.1%+6.3%$1.14B$631.45M34.75210News CoverageAnalyst UpgradeInsider TradeNTLAIntellia Therapeutics4.595 of 5 stars$10.74-0.5%$30.68+185.7%-50.1%$1.11B$57.88M-2.29600Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Canopy Growth Competitors Cronos Group Competitors Organigram Global Competitors SNDL Competitors Tilray Brands Competitors Village Farms International Competitors Xeris Biopharma Competitors Phibro Animal Health Competitors Collegium Pharmaceutical Competitors Intellia Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access